Brief: Windtree Therapeutics Inc - QTRLY Loss Per Share $4.76
15/05/2023 22:36
Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS INC - QTRLY LOSS PER SHARE $4.76
* WINDTREE THERAPEUTICS - AS OF MARCH 31, 2023, THE COMPANY
REPORTED CASH AND CASH EQUIVALENTS OF $4.2
Source text for Eikon: ID:
Further company coverage: WINT.O
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study